Cumberland Pharmaceuticals Inc.
Thromboxane Receptor Antagonists in AERD/Asthma

Abstract:

The present invention is directed to methods of treating AERD (aspirin exacerbated respiratory disease) and/or asthma via the administration of a thromboxane receptor antagonist to a patient in need thereof.